About $40B Of Drug Pricing Bill’s $288B In Savings At Risk During Byrd Bath

By John Wilkerson / July 21, 2022 at 5:37 PM
Staff for Senate Democrats and Republicans meet with the parliamentarian Thursday (July 21) to debate whether provisions of drug pricing legislation are allowed in Democrats’ budget reconciliation bill, and about $40 billion of the bill’s $288 billion in savings is at risk if Republicans try to eliminate drug inflation rebates that are calculated on commercial market drug sales. The parliamentarian is not expected to decide for a couple of days. Senate Finance Chair Ron Wyden (D-OR) said he is confident...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.